Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma.

Saved in:
Bibliographic Details
Title: Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma.
Authors: George L; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK., Taylor AR; GSK Respiratory Therapeutic Area Unit, Stevenage, UK., Esteve-Codina A; Centre for Genomic Regulation, CNAG-CRG Centre Nacional d'Anàlisi Genòmica, Barcelona Institute for Science and Technology, Barcelona, Spain., Soler Artigas M; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.; Centre for Genomic Regulation, CNAG-CRG Centre Nacional d'Anàlisi Genòmica, Barcelona Institute for Science and Technology, Barcelona, Spain.; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain., Thun GA; Centre for Genomic Regulation, CNAG-CRG Centre Nacional d'Anàlisi Genòmica, Barcelona Institute for Science and Technology, Barcelona, Spain., Bates S; GSK Respiratory Therapeutic Area Unit, Stevenage, UK., Pavlidis S; Airway Disease Section, National Heart & Lung Institute, Imperial College London, London, UK.; Data Science Institute, Imperial College London, London, UK., Wagers S; Biosci Consulting, Maasmechelen, Belgium., Boland A; Institut de Génomique, CEA, CNG Centre National de Génotypage, Evry, France., Prasse A; Department of Pneumology, University Medical Center, Freiburg, Germany., Boschetto P; Department of Medical Sciences, University of Ferrara and Ferrara City Hospital, Ferrara, Italy., Parr DG; Department of Respiratory Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Nowinski A; Department of Respiratory Medicine, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland., Barta I; Department of Pathophysiology, National Koranyi Institute for TB and Pulmonology, Budapest, Hungary., Hohlfeld J; Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany., Greulich T; Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany.; Member of the German Center for Lung Research (DZL), Großhansdorf, Germany., van den Berge M; Department of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hiemstra PS; Department of Pulmonary Diseases, Leiden University Medical Center, University of Leiden, Leiden, The Netherlands., Timens W; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hinks T; University of Oxford, Oxford, UK., Wenzel S; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA., Siddiqui S; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK., Richardson M; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK., Venge P; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden., Heath S; Centre for Genomic Regulation, CNAG-CRG Centre Nacional d'Anàlisi Genòmica, Barcelona Institute for Science and Technology, Barcelona, Spain., Gut I; Centre for Genomic Regulation, CNAG-CRG Centre Nacional d'Anàlisi Genòmica, Barcelona Institute for Science and Technology, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Tobin MD; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK., Edwards L; GSK Respiratory Therapeutic Area Unit, Stevenage, UK., Riley JH; GSK Respiratory Therapeutic Area Unit, Stevenage, UK., Djukanovic R; NIHR Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, Southampton, UK., Auffray C; European Institute for Systems Biology and Medicine (EISBM), CNRS-ENS-UCBL, Université de Lyon, Lyon cedex 07, France., De-Meulder B; European Institute for Systems Biology and Medicine (EISBM), CNRS-ENS-UCBL, Université de Lyon, Lyon cedex 07, France., Erik-Dahlen S; Karolinska Institute, Stockholm, Sweden., Adcock IM; Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain., Chung KF; Instituto de Salud Carlos III, Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain., Ziegler-Heitbrock L; EvA Study Center, Helmholtz Zentrum Muenchen and Asklepios-Klinik, Gauting, Germany., Sterk PJ; Department Respiratory Medicine, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, The Netherlands., Singh D; Centre for Respiratory Medicine and Allergy, The University of Manchester, Manchester, UK.; Medicines Evaluation Unit, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK., Brightling CE; Institute for Lung Health, Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK.
Corporate Authors: U-BIOPRED and the EvA study teams
Source: Allergy [Allergy] 2020 Feb; Vol. 75 (2), pp. 370-380. Date of Electronic Publication: 2019 Sep 10.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1398-9995
DOI:10.1111/all.14016